Results 21 to 30 of about 961,893 (364)
Coupling chemotaxis and growth poromechanics for the modelling of feather primordia patterning [PDF]
Mathematics, year 2022, volume 10, paper 4096, 2022 We propose a new mathematical model for the interaction of skin cell populations with fibroblast growth factor and bone morphogenetic protein, occurring within deformable porous media. The equations for feather primordia pattering are based on the work by K.J. Painter et al. [J. Theoret. Biol., 437 (2018) 225--238].
arxiv +1 more source
Fibroblast growth factor 23 and bone mineralisation [PDF]
International Journal of Oral Science, 2015 Fibroblast growth factor 23 (FGF23) is a hormone that is mainly secreted by osteocytes and osteoblasts in bone. The critical role of FGF23 in mineral ion homeostasis was first identified in human genetic and acquired rachitic diseases and has been further characterised in animal models.
Yuchen Guo, Quan Yuan
openaire +3 more sources
Action potential propagation and block in a model of atrial tissue with myocyte-fibroblast coupling [PDF]
Mathematical Medicine and Biology: A Journal of the IMA 38(1),
106-131 (2021), 2020 The electrical coupling between myocytes and fibroblasts and the spacial distribution of fibroblasts within myocardial tissues are significant factors in triggering and sustaining cardiac arrhythmias but their roles are poorly understood. This article describes both direct numerical simulations and an asymptotic theory of propagation and block of ...
arxiv +1 more source
Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia. [PDF]
Endocrinol Metab (Seoul)Fibroblast growth factor 23 (FGF23) is a pivotal humoral factor for the regulation of serum phosphate levels and was first identified in patients with autosomal dominant hypophosphatemic rickets and tumor-induced osteomalacia (TIO), the most common form ...
Ito N, Hidaka N, Kato H.
europepmc +2 more sources
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism
PLoS ONE, 2022 This ad hoc analysis of a previously conducted phase 3 head-to-head comparison study of evocalcet and cinacalcet in secondary hyperparathyroidism patients undergoing maintenance hemodialysis evaluated the efficacy and safety of combined once-daily oral ...
Takashi Shigematsu +5 more
doaj +2 more sources
Iron and fibroblast growth factor 23 in X-linked hypophosphatemia [PDF]
, 2014 Background Excess fibroblast growth factor 23 (FGF23) causes hypophosphatemia in autosomal dominant hypophosphatemic rickets (ADHR) and X-linked hypophosphatemia (XLH). Iron status influences C-terminal FGF23 (incorporating fragments plus intact FGF23)
Econs, Michael J. +3 more
core +1 more source
Fibroblast Growth Factor 23 and Inflammation in CKD [PDF]
Clinical Journal of the American Society of Nephrology, 2012 Summary Background and objectives Levels of fibroblast growth factor 23 (FGF23) and inflammatory markers are commonly elevated in CKD, and each is associated with adverse clinical outcomes. This study tested the hypothesis that FGF23 is independently associated with inflammation in CKD.
Sankar D. Navaneethan +14 more
openaire +2 more sources
Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale
Giornale di Clinica Nefrologia e Dialisi, 2015 non disponibile (Cardionephrology)
Luca Di Lullo +6 more
doaj +1 more source
Journal of Medical Case Reports, 2020 Background Neurofibromatosis type 1 is characterized by multiple café au lait spots and cutaneous and plexiform neurofibromas, and is one of the most common autosomal dominant hereditary disorders caused by mutations of the neurofibromatosis type 1 tumor
Takahiko Obo +4 more
doaj +1 more source
Serum intact fibroblast growth factor 23 in healthy paediatric population
Open Medicine, 2021 It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent.
Stanczyk Malgorzata +3 more
doaj +1 more source